Julianne Nemes Walsh, MS, PNP-BC NAPNAP Spring Symposium April, 2013 State of the State: Nurse Practitioner Practice in Massachusetts.
An Open-label, Randomized, Parallel-Group Trial of Zalutumumab, a Human Monoclonal Anti–EGF Receptor Antibody, in Combination With Best Supportive Care,